期刊
MOLECULAR CELL
卷 35, 期 4, 页码 511-522出版社
CELL PRESS
DOI: 10.1016/j.molcel.2009.08.002
关键词
-
资金
- Danish Cancer Society [DP06133]
- Danish National Research Foundation
- Danish Cancer Research Foundation [84-05, 47-07]
- Novo Nordisk Foundation
- Danish Medical Research Council [22-02-0136, 271-08-0642]
- US NIH [R01 CA092354, R01 GM71434]
- Roy and Lynne Frank Foundation
- Children's Hospital Boston
The RAS-stimulated RAF-MEK-ERK pathway confers epithelial cells with critical motile and invasive capacities during development, tissue regeneration, and carcinoma progression, often via promoting the epithelial-mesenchymal transition (EMT). Many mechanisms by which ERK exerts this control remain elusive. We demonstrate that the ERK-activated kinase RSK is necessary to induce mesenchymal motility and invasive capacities in nontransformed epithelial and carcinoma cells. RSK is sufficient to induce certain motile responses. Expression profiling analysis revealed that a primary role of RSK is to induce transcription of a potent promotile/invasive gene program by FRA1-dependent and -independent mechanisms. The program enables RSK to coordinately modulate the extracellular environment, the intracellular motility apparatus, and receptors mediating communication between these compartments to stimulate motility and invasion. These findings uncover a mechanism whereby the RAS-ERK pathway controls epithelial cell motility by identifying RSK as a key effector, from which emanate multiple highly coordinate transcription-dependent mechanisms for stimulation of motility and invasive properties.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据